Success Metrics

Active Trials
2(67%)

Phase Distribution

Ph not_applicable
1
33%
Ph phase_2
1
33%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Phase 2Efficacy & side effects
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Other(1)

Detailed Status

Recruiting2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 21 (50.0%)
N/A1 (50.0%)

Trials by Status

recruiting267%
unknown133%

Recent Activity

2 active trials
Showing 3 of 3
recruitingphase_2

Embryonal Tumor With Multilayered Rosettes

NCT06861244
recruiting

Shunt-dependency After aSAH - Role of Early Hyperglycaemia in CSF and Blood

NCT06486909
unknownnot_applicable

Neuroinflammation in Amyotrophic Lateral Sclerosis - Mechanisms and Therapeutic Perspectives: a Translational Pilot Study Among ALS Patients

NCT02424669

Clinical Trials (3)

Showing 3 of 3 trials
NCT06861244Phase 2

Embryonal Tumor With Multilayered Rosettes

Recruiting
NCT06486909

Shunt-dependency After aSAH - Role of Early Hyperglycaemia in CSF and Blood

Recruiting
NCT02424669Not Applicable

Neuroinflammation in Amyotrophic Lateral Sclerosis - Mechanisms and Therapeutic Perspectives: a Translational Pilot Study Among ALS Patients

Unknown

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3